Search Results for: covid-19
Articles
Vaxart Announces Positive Preclinical Data for its Oral COVID-19 Vaccine Program
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, recently...Ascendia Joins the Fight Against COVID-19; Developing Formulations
Ascendia Pharmaceuticals, a specialty CDMO company engaged in the design, formulation, optimization, and manufacture of poorly soluble molecules for various...COVID-19: Gattefossé Takes Measures & Continues to be Operational
Gattefossé - provider of personal care ingredients and pharmaceutical excipients - is committed to ensuring the protection of its employees...New COVID-19 Clinical Trial Supported by Octapharma USA
Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, CA, focused on treating the most critical patients at the….
HALIX Enters Collaboration for GMP Manufacturing of a COVID-19 Vaccine
HALIX B.V. has recently joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of….
Biomarkers Heavily Used as Diagnostic Tools in COVID-19 Trials
Biomarkers are a beneficial tool in the search for a COVID-19 vaccine and will help speed up clinical trials, reduce...7 Hills Pharma Announces COVID-19 Vaccine Program Targeting At-Risk Elderly
7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer...OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19
OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….
Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….
Cytovia Therapeutics & Macromoltek to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
Cytovia Therapeutics recently announced it is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis. Natural...
